EquipX Partners with Vizient for Enhanced Healthcare Solutions

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...

Going, Going, Gone? A Golf Exec's Dream Home What's hotter than Florida's summer sun? It's this swanky estate at Ponte Vedra Beach set to hit the auction block without any safety net. Yup, no reserve, folks! Leonard "Len" Brown, Jr., the brains behind many of PGA Tour's global ventures, has decided to put his lavish 3.2-acre plot right by the ocean up for grabs. Once...

Graph Intelligence: The Winning Edge You know, the financial crime scene ain't what it used to be. Gone are the days when a simple audit trail was enough to sniff out dirty money. Companies like Linkurious are pushing the envelope with graph-powered decision intelligence, and in 2026, they got the nod from Chartis Research as a Category Leader for AML Transaction...

Fort Bend County: The Next Step in Encompass Health's Journey Kicking off with some Texas flair, Encompass Health is making notable moves in Fort Bend County, venturing to boost its presence in the greater Houston area. It's no surprise given that this neck of the woods is seeing quite the growth spurt lately. Encompass Health, no stranger to living large, is charting new...

Pending Storm Over PG&E's Service Delays It's rare that you hear a utility company flat-out say it can't afford to keep the lights on. Yet here we are, staring down the barrel of some unsettling news for 25,000 PG&E customers. They've been warned they might cool their heels for an extra six months before their service is up and running. As if that's not dicey enough, $2...

Shaking Up Loyalty: TrueLoyal's Bold Move You know, in an era when brands are trying everything to keep customers from jumping ship, getting someone like Erica Thompson on board is like snagging a golden ticket. TrueLoyal just announced they’ve tapped into a veteran, a real heavy-hitter in the loyalty game, to head their loyalty strategy, customer retention, and...

Coastal Financial Corporation's (NASDAQ:CCB) recent nosedive is more distressing than a rollercoaster ride. After a 43.52% stock drop, investors are furious, to say the least. What tipped the scales? Coastal's financial revelations painted a bleak picture, but that’s just scratching the surface of a mess that has folks heading for legal battles. Behind the Numbers: The...

When Insiders Seem to Benefit More Ah, mergers and acquisitions—it's the oldest tango in the business world. But today, we've got some footwork that might trip up the small fry. Halper Sadeh LLC, the investor rights bulldogs, are sniffing around Surgery Partners, Range Resources, and EQT. Their quest? To uncover whether the big dogs are playing unfairly with...

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Avery Dennison Corporation's Promising Growth Potential Avery Dennison Corporation (NYSE: AVY) is a notable player in the material science sector, focusing on labeling and packaging solutions. The company recently attracted attention from Barclays, which has issued an 'Overweight' rating on its stock, accompanied by a price target set at $250. This assessment signifies...

AMMO, Inc. Investor Update: Legal Rights and Options Investors in AMMO, Inc. face a challenging time as the company's recent disclosures raise concerns about its internal financial controls. A recent investigation has been initiated by Faruqi & Faruqi, LLP, a national law firm specializing in securities litigation, which may affect investor positions. If you have...

Renew's Leadership Boost: Key Hires for Growth Renew, a trailblazer in the real estate industry known for its unique renewal and retention management platform, has recently bolstered its leadership team. This strategic enhancement comes with the addition of two seasoned executives, aimed at accelerating growth and fostering deeper customer interactions. Powerful New...

Inflation Data and Its Impact on the Crypto Market The U.S. Commerce Department recently announced that the key inflation rate slightly increased, which sent waves across the crypto markets. The inflation rate for September edged up to 2.1%, moving closer to the target set by the Federal Reserve. Investors are carefully analyzing this information, particularly as it...

Fulcrum's Tumultuous Turn June's supposed summer warmth brought a chill to Fulcrum Therapeutics' investors as a severe plunge shook NASDAQ:FULC to its core. One isn't surprised that Levi & Korsinsky is sniffing around, seeing potential treachery afoot. The pot boiled over after Fulcrum disclosed the discontinuation of pociredir—it's enough to send anyone's blood...